New review article highlights Nevisense effectiveness in identifying malignant skin lesions

STOCKHOLM, Jan. 28, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a new review article has been published highlighting the performance of Nevisense in identifying…